Is serum phosphorus control related to parathyroid hormone control in dialysis patients with secondary hyperparathyroidism? [PDF]
, 2012 Background Elevated serum phosphorus (P) levels have been linked to increased morbidity and mortality in dialysis patients with secondary hyperparathyroidism (SHPT) but may be difficult to control if parathyroid hormone (PTH) is persistently elevated.
Braun, J. +5 more
core +4 more sources
Preclinical Pharmacokinetics, Pharmacodynamics and Safety of Sucroferric Oxyhydroxide. [PDF]
, 2014 Sucroferric oxyhydroxide (VELPHORO(®)) is a polynuclear iron-based phosphate binder recently approved for the treatment of hyperphosphataemia in patients with chronic kidney disease (CKD). As a number of the available phosphate binders do not provide the
Cozzolino, M. +4 more
core +1 more source
Frontiers in Medicine, 2021 Patients with end-stage renal disease (ESRD) present alterations in mineral and bone metabolism. Hyperphosphatemia in ESRD is considered an independent risk factor for cardiovascular disease (CVD), increasing morbidity, and mortality.
Elodia Nataly Díaz-De la Cruz +8 more
doaj +1 more source
Frontiers in Bioengineering and Biotechnology, 2022 As the most efficient method to treat hepatocellular carcinoma in the immediate or advanced stage, transarterial chemoembolization (TACE) is coming into the era of microsphere (MP).
Hong Chen +11 more
doaj +1 more source
Considerations about the effectiveness and cost effectiveness of therapies in the treatment of hyperphosphataemia [PDF]
, 2011 Because of an elevated serum phosphate level, patients who suffer from chronic kidney failure frequently tend to have cardiovascular calcification and are therefore exposed to a higher probability of a fatal event.
Mittendorf, Thomas +2 more
core +2 more sources
Phosphorus binders: preferences of patients on hemodialysis and its impact on treatment compliance and phosphorus control [PDF]
, 2010 Introducción: En la actualidad disponemos de un amplio abanico de captores del fósforo (CF), pero sabemos poco acerca de las preferencias de los pacientes y de su repercusión sobre el cumplimiento del tratamiento y el control de los niveles de fósforo ...
Arenas Jiménez, María Dolores +5 more
core +2 more sources
Colitis Associated With Sevelamer Carbonate: A Case Report
Annals of Internal Medicine: Clinical Cases, 2023 Sevelamer carbonate is an anion-exchange, nonabsorbable resin that is commonly used to treat hyperphosphatemia in patients with advanced chronic kidney disease and end-stage renal disease.
Prajwol Pant +4 more
doaj +1 more source
Pharmacological Management of Secondary Hyperparathyroidism in Patients with Chronic Kidney Disease [PDF]
, 2016 Secondary hyperparathyroidism (SHPT) is a common complication of CKD and is part of the chronic kidney disease-mineral bone disorder (CKD-MBD). SHPT is associated with increased risk of fracture and mortality, thus SHPT control is recommended as kidney ...
Khwaja, A., Salam, S.N., Wilkie, M.E.
core +1 more source
Macromolecular Rapid Communications, EarlyView.We report here a new methodology to prepare functional poly(acetylene)s under aqueous conditions. This methodology is underpinned by poly(O‐propargyl‐N‐amino carbamate) (P1), a reactive poly(acetylene) carrying acyl hydrazines. Thus, P1 reacts with aldehydes to give functional poly(acetylene)s, including cationic, hydrophobic, and sugar‐loaded poly ...
Tom Leigh +8 more
wiley +1 more source
New Conclusions Regarding Comparison of Sevelamer and Calcium-Based Phosphate Binders in Coronary-Artery Calcification for Dialysis Patients: A Meta-Analysis of Randomized Controlled Trials. [PDF]
PLoS ONE, 2015 Sevelamer hydrochloride is used widely, but its impact upon cardiovascular calcification, cardiovascular mortality, all-cause mortality and hospitalization is not known.Primary outcome was cardiovascular calcification (coronary artery calcification ...
Caixia Wang +6 more
doaj +1 more source